Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07756268
What this trial is testing

Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Tongji Hospital 25
Early research (Phase 1)Study completedNCT04557306
What this trial is testing

Evaluationn of Tolerability and Safety of CBT101, an Autologous Natural Killer Cell, in Patients With Solid Cancer

Who this might be right for
Solid Tumor
CHABiotech CO., Ltd 6
Not applicableNot Yet RecruitingNCT07034755
What this trial is testing

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)Chimeric Antigen Receptor T-cell
The Affiliated Hospital of Xuzhou Medical University 20
Testing effectiveness (Phase 2)Ended earlyNCT02427776
What this trial is testing

A Trial for Evaluating Both Safety and Preliminary Efficacy of a Single Infusion of Stimulated Autologous CD4+T Cells in Patients With Relapsing- Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Imcyse SA 2
Testing effectiveness (Phase 2)Study completedNCT00053391
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
University Hospital Erlangen 62
Testing effectiveness (Phase 2)Study completedNCT00986518
What this trial is testing

T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study

Who this might be right for
Colorectal Cancer
Assistance Publique - Hôpitaux de Paris 5
Large-scale testing (Phase 3)WithdrawnNCT03997318
What this trial is testing

Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1)

Who this might be right for
Stress Urinary Incontinence
Cook MyoSite
Early research (Phase 1)WithdrawnNCT02245698
What this trial is testing

Autologous Stem Cell Therapy in Stroke

Who this might be right for
Stroke
Neurogen Brain and Spine Institute
Not applicableNot Yet RecruitingNCT06661863
What this trial is testing

Effectiveness of Alveolar Bone Preservation in Alveoli With Infectious Process

Who this might be right for
Alveolar Bone Loss
Universidad de Especialidades Espiritu Santo 28
Early research (Phase 1)Study completedNCT03137914
What this trial is testing

Nasal Septum Autologous Chondrocytes Transplantation for Condylar Resorption After Orthognathic Surgery

Who this might be right for
Temporomandibular Joint Disorders
Faculdade de Medicina de Petrópolis Faculdade Arthur Sá Earp Neto 10
Not applicableLooking for participantsNCT07179484
What this trial is testing

To Evaluate the Efficacy of CT041 in Sequential Treatment After First-line Treatment of Advanced Gastric/Esophagogastric Junction Adenocarcinoma

Who this might be right for
Gastroesophageal Junction Adenocarcinoma
Beijing GoBroad Hospital 20
Not applicableStudy completedNCT00221715
What this trial is testing

Comparison of Two Lower Limb Bypass Types : Prosthesis Versus Autologous Vein

Who this might be right for
ArteritisDiabetes
University Hospital, Bordeaux 100
Post-approval studies (Phase 4)Study completedNCT00616135
What this trial is testing

Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy

Who this might be right for
Breast NeoplasmsCarcinoma, Ductal, BreastMammaplasty+1 more
Cytori Therapeutics 71
Early research (Phase 1)Study completedNCT01089985
What this trial is testing

Use of Autologous Serum Eye-drops as Tears in Patients With Recalcitrant Dry Eye

Who this might be right for
Xerophthalmia
Singapore National Eye Centre 10
Testing effectiveness (Phase 2)Study completedNCT02037204
What this trial is testing

IMPACT: Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.

Who this might be right for
Foreign-Body ReactionInflammationEffusion (L) Knee+1 more
UMC Utrecht 35
Early research (Phase 1)Looking for participantsNCT03081910
What this trial is testing

Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

Who this might be right for
T-cell Acute Lymphoblastic LymphomaT-non-Hodgkin LymphomaT-cell Acute Lymphoblastic Leukemia
Baylor College of Medicine 54
Early research (Phase 1)Study completedNCT04105582
What this trial is testing

Breast Cancer Neoantigen Vaccination With Autologous Dendritic Cells

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Universidad Nacional de Colombia 5
Testing effectiveness (Phase 2)Looking for participantsNCT05632380
What this trial is testing

ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492050
What this trial is testing

Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
M.D. Anderson Cancer Center 46
Early research (Phase 1)Study completedNCT02955550
What this trial is testing

A Safety Study of Human Cord Blood Derived, Culture-expanded, Natural Killer Cell (PNK-007) Infusion With or Without Subcutaneous Recombinant Human Interleukin-2 (rhIL-2) Following Autologous Stem Cell Transplant for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Celularity Incorporated 15
Next Page